Bladder cancer Treatment in Uni-asia Cancer hospital

Uni-asia Cancer Hospital in Chengdu, China, provides treatment for bladder cancer using minimally invasive and bladder-preserving methods. Patients can access specialist expertise through online consultations for around $150, while advanced imaging like a PET/CT or full-body CT scan typically costs around $1,300. The medical team is led by Prof. M.D. Liao Zhengyin, who brings over 25 years of experience and has performed 100,000+ procedures.

The hospital focuses on a multidisciplinary approach for complex tumors. Prof. M.D. Liao Zhengyin, a former director at West China Hospital and a visiting scholar at Johns Hopkins Hospital, heads the team. The facility uses a variety of advanced tools, including cryoablation, NanoKnife, and iodine-125 seed implantation, to treat cancer without extensive surgery when possible.

Diagnostic and consultation options

Accurate staging is necessary to choose between surgical and non-surgical paths. The clinic offers several diagnostic services to assess tumor depth and spread:

• Online consultation with oncologist. A remote session to review medical history and plan next steps, costing around $150.
• CT scan of the whole body. Detailed imaging to check for metastasis, priced around $1,300.
• PET/CT. Advanced metabolic imaging used for precise cancer staging, costing around $1,300.

Surgical and minimally invasive treatments

The choice of surgery depends on whether the cancer has reached the bladder muscle. The clinic offers both standard and laser-assisted procedures:

• TURBT (transurethral resection of bladder tumor). An endoscopic procedure to remove non-muscle-invasive tumors and provide accurate staging.
• Transurethral laser therapy. Precise tumor removal using laser vaporization or enucleation, which helps reduce bleeding and perforation risks.
• Radical cystectomy. The removal of the bladder and lymph nodes for muscle-invasive cancer, featuring options for urinary diversion or an orthotopic neobladder.
• Intravesical instillation therapy. A postoperative treatment where drugs are placed directly into the bladder to help prevent the cancer from returning.

Non-surgical and bladder-preserving strategies

For patients who cannot undergo major surgery or wish to keep their bladder, the hospital provides several medical alternatives. These methods target the cancer cells while maintaining organ function.

Bladder-preserving multimodality therapy combines a maximal TURBT with concurrent cisplatin-based chemoradiotherapy. For advanced or refractory cases, the hospital uses targeted therapy with FGFR inhibitors for specific genetic mutations. Immunotherapy using checkpoint inhibitors and antibody-drug conjugates is also available for patients who do not respond to standard platinum-based chemotherapy. These precision therapies help achieve durable responses in difficult cases.

You may request a consultation on Bookimed to discuss these treatment options with the medical team at Uni-asia Cancer Hospital.